MIR5584: A Potential Drug Target and Biomarker (G100847089)
MIR5584: A Potential Drug Target and Biomarker
MIR5584 is a protein that is expressed in various tissues of the body, including the lungs, heart, liver, and pancreas. It is a member of the Mucinage family of proteins, which are involved in the production of mucin, a component of connective tissue. MIR5584 has been identified as a potential drug target and biomarker due to its unique structure and the involvement of various diseases, including cancer, cardiovascular disease, and diabetes.
The MIR5584 protein is composed of 114 amino acid residues and has a calculated molecular weight of 19.1 kDa. It is expressed in various tissues of the body and has been shown to be involved in various physiological processes, including cell signaling, inflammation, and immune response.
One of the most significant functions of MIR5584 is its role in cell signaling. It is a protein that is involved in the regulation of cell growth, differentiation, and survival. MIR5584 has been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that MIR5584 is overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that MIR5584 may be a useful target for cancer therapies that target the regulation of cell growth and survival.
MIR5584 is also involved in the regulation of inflammation. It has been shown to be involved in the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾. These cytokines can contribute to the development and progression of various inflammatory diseases, including cardiovascular disease and diabetes. The involvement of MIR5584 in the regulation of inflammation makes it a potential target for therapies that target inflammation and promote health.
In addition to its role in cell signaling and inflammation, MIR5584 is also involved in the regulation of immune response. It has been shown to be involved in the development and regulation of natural killer cells, which are important for immune surveillance and protection against viruses and other pathogens. The regulation of natural killer cells by MIR5584 may be a potential target for therapies that promote immune function and prevent the development of various diseases.
The potential drug targeting of MIR5584 is based on its unique structure and the involvement of various diseases. MIR5584 has been shown to be involved in the regulation of cell growth, differentiation, and survival, as well as the production of pro-inflammatory cytokines. It is also involved in the regulation of inflammation and immune response. These functions make MIR5584 a potential target for drugs that promote health and prevent the development of various diseases.
In conclusion, MIR5584 is a protein that is expressed in various tissues of the body and has been shown to be involved in various physiological processes, including cell signaling, inflammation, and immune response. Its unique structure and involvement in the regulation of cell growth, differentiation, and survival make it a potential drug target and biomarker. Further research is needed to fully understand the role of MIR5584 in the regulation of various diseases and to develop effective therapies that target its unique functions.
Protein Name: MicroRNA 5584
The "MIR5584 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR5584 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574 | MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075
